p53 Deficiency Leads to Compensatory Up-Regulation of p16 INK4a

Molecular Cancer Research

Volumn 7, Issue 3, 2009, Pages 354-360

  Wai, Fook Leong ^a   Jenny, Fung Ling Chau ^a   Baojie, Li ^a,b  

^a INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 2A; MUTANT PROTEIN; PROTEIN P21; PROTEIN P53; TRANSCRIPTION FACTOR ETS 1;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENE MUTATION; GENE SILENCING; GENOTOXICITY; HALF LIFE TIME; HUMAN; HUMAN CELL; METHYLATION; MOLECULAR INTERACTION; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY; PROTEIN TARGETING;

ANIMALS; BLOTTING, WESTERN; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FIBROBLASTS; MICE; PROTO-ONCOGENE PROTEIN C-ETS-1; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 62549158651     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-08-0373     Document Type: Article

References (22)

1. Vogelstein B, Laue D. Levine AJ. Surfing the p53 network. Nature 2000;408:307-10.
2. Vousden KH, Lane DP. p53 in health and disease. Nat Rev Mol Cell Biol 2007;8:275-83.
3. Wang X, Kua HY, Hu Y, et al. p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling. J Cell Biol 2006;172:115-25.
4. Pei XH, Xiong Y. Biochemical and cellular mechanisms of mammalian CDK inhibitors: a few unresolved issues. Oncogene 2005;24:2787-95.
5. INk4 gene inactivation by hypermethylation in lung cancer during the process of metastasis and its relation to the status of p53. Clin Cancer Res 2000;6:4307- 13.
6. ARF predisposes mice to tumorigenesis. Nature 2001;413:86-91.
7. Sharpless NE, Alson S, Chan S, Silver DP, Castrillon DH, DePinho RA. p16(lNK4a) and p53 deficiency cooperate in tumorigenesis. Cancer Res 2002;62:2761-5.
8. Wang Y, Zhang Z, Kastens E, Lubet RA, You M. Mice with alterations in both p53 and INK4A/ARF display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice. Cancer Res 2003;63:4389-95.
9. Lin AW, Barradas M, Stone JC, van Aelst L, Serrano M, Lowe SW. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev 1998;12:3008-19.
10. Karsai S, Abel U, Roesch-Ely M, et al. Comparison of pl6(INK4a) expression with p53 alterations in head and neck cancer by tissue microarray analysis. J Pathol 2007;211:314-22.
11. INk4B/MTS2 genes in biliary tract cancers. Cancer Res 1995;55:2756-60.
12. INk4a expression during cellular senescence. Nature 2001;409:1067-70.
13. Gutierrez-Hartmann A, Duval DL, Bradford AP. ETS transcription factors in endocrine systems. Trends Endocrinol Metab 2007;18:150-8.
14. Seth A, Watson DK. ETS transcription factors and their emerging roles in human cancer. Eur J Cancer 2005;41:2462-78.
15. ARF senescence pathways. Genes Dev 2005;19:1432-7.
16. Iotsova V, Crepieux P, Montpellier C, Laudet V, Stehelin D. TATA-less promoters of some Ets-family genes are efficiently repressed by wild-type p53. Oncogene 1996;13:2331-7.
17. Tang Y, Eng C. p53 down-regulates phosphatase and tensin homologue deleted on chromosome 10 protein stability partially through caspase-mediated degradation in cells with proteasome dysfunction. Cancer Res 2006;66:6139-48.
18. Duursma A, Agami R. p53-dependent regulation of Cdc6 protein stability controls cellular proliferation. Mol Cell Biol 2005;25:6937-47.
19. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med 2004;10:789 - 99.
20. INK4a modulates p53 in primary human mammary epithelial cells. Cancer Res 2006;66:10325-31.
21. INK4a-silencing augments DNA damage-induced apoptosis in cervical cancer cells. Oncogene 2007;26:6050-60.
22. Higuchi T, Battel FO, Masuya M, et al. Thymomegaly, microsplenia, and defective homeostatic proliferation of peripheral lymphocytes in p51-l isoform-specific null mice. Mol Cell Biol 2007;27:3353-66.